Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/26/2003US6610302 Peptides for the treatment and amelioration of tumor-producing diseases, and methods for their utilization.
08/26/2003US6610301 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
08/26/2003US6610300 Clostridium perfringens vaccine
08/26/2003US6610297 Compositions for treating allergies that include either BSW17 mimotope peptides or antibodies raised against BSW17 mimotope peptides. Also disclosed are methods for the treatment of allergies which involve administration of BSW17 mimeotope
08/26/2003US6610296 Therapy for central nervous system disorders
08/26/2003US6610295 HCMV glycoproteins B and H have been identified. The gB protein is encoded by DNA in the HindIII F fragment of the HCMV genome lying between 1378 and 4095 bases from the F/D boundary. The gH protein is encoded by DNA in the HindIII L
08/26/2003US6610294 Methods of inhibiting an autoimmune response in a human suffering from an autoimmune disease by administering an antibody that binds to a protein to which monoclonal antibody 5C8 binds
08/26/2003US6610293 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
08/26/2003US6610290 Transferring preferential nucleotide sequences to cells; obtain cells, incubate with expression vector, transform cells, recover transformed cells
08/26/2003US6610286 Administering interleukin antagonist
08/26/2003US6610285 A full-length cDNA corresponding to an EST (AA418955), which does not show any homology to other proteins in the database but has a weak homology to G-CSF, has been successfully isolated by synthesizing primers based on the EST sequence,
08/26/2003CA2277896C Preparation of collagen
08/26/2003CA2220063C Acellular pertussis vaccines and methods of preparation thereof
08/25/2003CA2405347A1 Medicament comprising nk4 gene or recombinant nk4 protein
08/21/2003WO2003069347A2 Diagnostic and therapeutic use of caps
08/21/2003WO2003069342A1 A method of screening
08/21/2003WO2003069337A1 Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
08/21/2003WO2003068993A1 Method for isolation and purification of expressed gene products in vitro
08/21/2003WO2003068977A2 Fusion constructs containing active sections of tnf ligands
08/21/2003WO2003068973A1 Dna sequence useful in diagnosing hepatitis and polypeptide encoded thereby
08/21/2003WO2003068972A1 Ethylene-response trancriptional coactivators in plant
08/21/2003WO2003068971A1 Method of expressing an encoding sequence by xenoplus cells
08/21/2003WO2003068970A1 Sodium-independent transporter carrying acidic amino acid and its gene
08/21/2003WO2003068969A1 Mouse spermatogenesis genes, human male sterility-associated genes and diagnostic system using the same
08/21/2003WO2003068968A2 Mutated gene coding for a lat protein and the biological applications thereof
08/21/2003WO2003068967A2 Novel retina specific human proteins wdr17, net01, protein kinase a203, protein kinase mak a194, protein a105, protein a106 and c12orf3variants
08/21/2003WO2003068966A2 REGULATION OF HUMAN Ca2+-PERMEABLE NONSELECTIVE CATION CHANNEL
08/21/2003WO2003068965A1 Isolated probes specific for g protein - coupled receptors and genes encoding same and diagnostic uses therefor
08/21/2003WO2003068959A1 Novel screening method
08/21/2003WO2003068954A2 Microorganism for genetic therapeutic treatment of proliferative diseases
08/21/2003WO2003068952A1 Stat3 activated stem cell
08/21/2003WO2003068950A1 Tissue-type plasminogen activator (t-pa) inhibitors with a therapeutic capacity
08/21/2003WO2003068943A2 Secreted proteins
08/21/2003WO2003068941A2 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003WO2003068940A2 Complexes and methods of using same
08/21/2003WO2003068934A2 Chimeric molecules for cleavage in a treated host
08/21/2003WO2003068933A2 Optimization of gene sequences of virus-like particles for expression in insect cells
08/21/2003WO2003068930A2 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
08/21/2003WO2003068925A2 Production of a protein delivery system for in vivo therapeutic treatment
08/21/2003WO2003068921A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2003068919A2 Non-invasive method for measuring rates of biosynthesis of biological molecules by label incorporation
08/21/2003WO2003068912A2 PSEUDOMONAS SYRINGAE HARPINS, HopPtoP AND HopPmaHPTO, AND THEIR USES
08/21/2003WO2003068911A2 Citrus tristeza virus resistance genes and methods of use
08/21/2003WO2003068822A2 De-immunized (poly)peptide constructs
08/21/2003WO2003068818A1 Novel glutamate receptor and utilization thereof
08/21/2003WO2003068817A1 Management of mucosal viscosity by tff monomer peptides
08/21/2003WO2003068816A1 Mhc class i peptide epitopes from the human 5t4 tumor-associated antigen
08/21/2003WO2003068815A2 Mhc class ii peptide epitope of 5t4 antigen
08/21/2003WO2003068814A1 Novel genes functionally related to dyslexia
08/21/2003WO2003068813A2 Group b streptococcus antigen
08/21/2003WO2003068812A2 Immune-modulating peptide made of s. aureus enterotoxin b
08/21/2003WO2003068811A2 Cytotoxic t-cell epitopes from chlamydia
08/21/2003WO2003068810A1 A dna sequence and encoded polypeptide useful in the diagnosis of hepatitis disease
08/21/2003WO2003068809A2 An herpes simplex virus complex
08/21/2003WO2003068808A1 Novel protein complexes and uses therefor
08/21/2003WO2003068805A2 Formulation strategies in stabilizing peptides in organic solvents and in dried states
08/21/2003WO2003068804A2 Novel insect cell line
08/21/2003WO2003068803A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
08/21/2003WO2003068802A2 Materials and methods for preparing dimeric growth factors
08/21/2003WO2003068800A2 Isolated peptides which bind to hla molecules and uses thereof
08/21/2003WO2003068799A2 Oligomeric molecules and uses thereof
08/21/2003WO2003068798A2 Oligonucleotide analogues and methods of use for modulating gene expression
08/21/2003WO2003068787A1 Bi-functionalised metallocenes use for marking biological molecules
08/21/2003WO2003068170A2 Enzyme treatment of foodstuffs for celiac sprue
08/21/2003WO2003068169A2 Stabilized synthetic immunogen delivery system
08/21/2003WO2003068168A2 Helical peptidomimetics and use b-amyloid-associated diseases
08/21/2003WO2003068163A2 Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
08/21/2003WO2003068146A2 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/21/2003WO2003067965A2 Identification and characterization of an glutamine dumper 1 phenotype (gdui1) in arabidopsis
08/21/2003WO2003059385A3 Hiv vaccine and method of use
08/21/2003WO2003055913A3 Secreted protein
08/21/2003WO2003055904A3 Peptidyl-trna hydrolase from pseudomonas aeruginosa
08/21/2003WO2003054014A3 Apolipoprotein biopolymer markers predictive of alzheimers disease
08/21/2003WO2003044056A3 Chemically-modified human growth hormone conjugates
08/21/2003WO2003042245A3 Growth hormone variations in humans and their uses
08/21/2003WO2003040394A3 Production of recombinant proteins in vivo and use for generating antibodies
08/21/2003WO2003025176B1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
08/21/2003WO2003025156A3 Methods and apparatuses for purification
08/21/2003WO2003024474A3 Anti-inflammatory agent
08/21/2003WO2003024308A3 Methods of assaying connective tissue growth factor
08/21/2003WO2003022881A3 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins
08/21/2003WO2003022204A3 Measles vaccine vectors and methods of use
08/21/2003WO2003018620A3 Serine protease inhibitor and processes for the preparation thereof
08/21/2003WO2003018052A8 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
08/21/2003WO2003016471A3 Periostin-based diagnostic assays
08/21/2003WO2003015708A8 Composition and method for treating hiv infection
08/21/2003WO2003006070A3 Improved chelator conjugates
08/21/2003WO2003004006A8 Use of potent, selective and non toxic c-kit inhibitors for treating tumor angiogenesis
08/21/2003WO2003002751A3 Alteration of oil traits in plants
08/21/2003WO2003000718A3 Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome
08/21/2003WO2002097127A3 Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease
08/21/2003WO2002095030A3 Modulation of cd200 receptors
08/21/2003WO2002092620A3 Peptides and related molecules that bind to tall-1
08/21/2003WO2002086125A3 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour
08/21/2003WO2002083901A3 Plant growth regulating genes, proteins and uses thereof
08/21/2003WO2002083838A3 Elimination of endogenous porcine retrovirus
08/21/2003WO2002082075A3 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
08/21/2003WO2002081692A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
08/21/2003WO2002079398A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
08/21/2003WO2002077236A3 Compositions and methods relating to lung specific genes and proteins
1 ... 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 ... 2916